EKF Diagnostics Holdings plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that pr… Read more
Market Cap & Net Worth: EKF Diagnostics Holdings plc (EKDHF)
EKF Diagnostics Holdings plc (PINK:EKDHF) has a market capitalization of $153.74 Million ($153.74 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #17133 globally and #6533 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EKF Diagnostics Holdings plc's stock price $0.36 by its total outstanding shares 431963112 (431.96 Million).
EKF Diagnostics Holdings plc Market Cap History: 2015 to 2025
EKF Diagnostics Holdings plc's market capitalization history from 2015 to 2025. Data shows growth from $77.02 Million to $153.74 Million (0.00% CAGR).
EKF Diagnostics Holdings plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EKF Diagnostics Holdings plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.06x
EKF Diagnostics Holdings plc's market cap is 3.06 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
24.63x
EKF Diagnostics Holdings plc's market cap is 24.63 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $77.02 Million | $30.05 Million | -$37.12 Million | 2.56x | N/A |
| 2016 | $72.83 Million | $38.59 Million | -$18.00K | 1.89x | N/A |
| 2017 | $139.22 Million | $41.58 Million | $2.71 Million | 3.35x | 51.28x |
| 2018 | $165.31 Million | $42.54 Million | $10.11 Million | 3.89x | 16.35x |
| 2019 | $157.41 Million | $44.92 Million | $3.68 Million | 3.50x | 42.80x |
| 2020 | $275.51 Million | $65.26 Million | $11.11 Million | 4.22x | 24.79x |
| 2021 | $453.60 Million | $81.84 Million | $15.85 Million | 5.54x | 28.62x |
| 2022 | $130.45 Million | $66.64 Million | -$9.58 Million | 1.96x | N/A |
| 2023 | $130.67 Million | $52.61 Million | $2.35 Million | 2.48x | 55.56x |
| 2024 | $153.74 Million | $50.19 Million | $6.24 Million | 3.06x | 24.63x |
Competitor Companies of EKDHF by Market Capitalization
Companies near EKF Diagnostics Holdings plc in the global market cap rankings as of March 19, 2026.
Key companies related to EKF Diagnostics Holdings plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
EKF Diagnostics Holdings plc Historical Marketcap From 2015 to 2025
Between 2015 and today, EKF Diagnostics Holdings plc's market cap moved from $77.02 Million to $ 153.74 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $153.74 Million | 0.00% |
| 2024 | $153.74 Million | +17.65% |
| 2023 | $130.67 Million | +0.17% |
| 2022 | $130.45 Million | -71.24% |
| 2021 | $453.60 Million | +64.64% |
| 2020 | $275.51 Million | +75.03% |
| 2019 | $157.41 Million | -4.78% |
| 2018 | $165.31 Million | +18.74% |
| 2017 | $139.22 Million | +91.16% |
| 2016 | $72.83 Million | -5.44% |
| 2015 | $77.02 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of EKF Diagnostics Holdings plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $153.74 Million USD |
| MoneyControl | $153.74 Million USD |
| MarketWatch | $153.74 Million USD |
| marketcap.company | $153.74 Million USD |
| Reuters | $153.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.